Get the Stockscreener App
183.82
2.56%
4.59
After Hours:
183.82
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $183.82, with a volume of 1.45M.
It is up +2.56% in the last 24 hours and down -3.14% over the past month.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
See More
Previous Close:
$179.23
Open:
$179.22
24h Volume:
1.45M
Relative Volume:
0.74
Market Cap:
$50.07B
Revenue:
$21.37B
Net Income/Loss:
$1.41B
P/E Ratio:
46.61
EPS:
3.9437
Net Cash Flow:
$3.07B
1W Performance:
+1.59%
1M Performance:
-3.14%
6M Performance:
+16.14%
1Y Performance:
+1.79%
1-Day Range:
$177.87
$183.92
1-Week Range:
$177.87
$184.37
52-Week Range:
$140.11
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
183.82 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
405.18 | 143.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
RMD
Resmed Inc
|
222.00 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.47 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.70 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Resumed | Goldman | Neutral |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Could Becton Dickinson (NYSE:BDX) Reset Its Market Story? - Kalkine Media
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors - MarketWatch
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Arthur Hu to Join BD as Chief Information and Digital Officer – Company Announcement - Financial Times
Becton, Dickinson and Company (BDX) Stock Analysis: Balancing Dividend Yield and Growth Potential - DirectorsTalk Interviews
Becton Dickinson (BDX), Why Is Fresh Attention Building Around It? - simplywall.st
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Why Has Becton Dickinson (BDX) Returned to the Spotlight? - Kalkine Media
Becton, Dickinson And Company Deploys BD Vmax 160 Pharmacy Automation Robot At Fairview Health Services - marketscreener.com
Becton, Dickinson and Company (BDX) Stock Analysis: A Healthcare Giant with a 10% Potential Upside - DirectorsTalk Interviews
Fairview fills an average of 20,000 prescriptions a week. It is first in the U.S. to deploy a pharmacy robot. - Stock Titan
Did $40 Million Verdict Just Shift BD's (BDX) Investment Narrative? - simplywall.st
Becton Dickinson (BDX) Could Be 10% Undervalued As Dividend Lands - simplywall.st
Becton, Dickinson at Wells Fargo healthcare conference: focus sharpens - Investing.com
Becton, Dickinson at Wells Fargo healthcare conference: focus sharpens By Investing.com - Investing.com UK
Transcript : Becton, Dickinson and Company Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 through Sep-10-2026 - marketscreener.com
Becton Dickinson & Co's Dividend Analysis - Yahoo Finance Singapore
Is Becton Dickinson (BDX) Still A Bargain After A 24% Gain? - simplywall.st
Is Becton Dickinson & Co (BDX) a Bargain After 3.0% Drop? GF Val - GuruFocus
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Jefferies Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $210 - Moomoo
Becton Dickinson & Co To Go Ex-Dividend On September 9th, 2026 With 1.05 USD Dividend Per Share - Moomoo
Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 5.91% Potential Upside in the Healthcare Giant - DirectorsTalk Interviews
How Is Becton, Dickinson and Company's Stock Performance Compared to Other Medical Devices Stocks? - Yahoo Finance
BECTON DICKINSON & CO CFO Roque Vitor Retains 8,041 Shares Following 190-Share Forfeiture - Kalkine Media
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Becton Dickinson (NYSE: BDX) CFO reports 190-share tax withholding - Stock Titan
Quote and Chart - Becton Dickinson
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $200 - Moomoo
Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Growth with a Solid Dividend Yield and Potential Upside - DirectorsTalk Interviews
BofA Adjusts Price Target on Becton Dickinson and Co. to $200 From $185 - Yahoo Finance
Becton Dickinson and Company (BDX) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Becton Dickinson (BDX) Hits STANCE Trial Milestone, Is The Stock Fully Valued? - simplywall.st
Becton Dickinson (NYSE: BDX) CRO sale leaves him with 19,720 shares - Stock Titan
Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Healthcare with a Strategic Edge - directorstalkinterviews.com
A continuous monitoring medtech vet charts the course to a less-invasive future - Medical Design & Outsourcing
16,962 Shares in Becton, Dickinson and Company $BDX Acquired by Wealthfront Advisers LLC - MarketBeat
Park West Asset Management LLC's Becton Dickinson & Co(BDX) Holding History - GuruFocus
Tocqueville Asset Management L.P. Raises Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Flossbach Von Storch SE Sells 8,875 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson stock extends its August rally as shares trade close to 52-week high - Ad-hoc-news.de
Danske Bank A S Decreases Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Foster & Motley Inc. Purchases New Position in Becton, Dickinson and Company $BDX - MarketBeat
A Look at Becton Dickinson & Co (BDX) After 3.8% Gain -- GF Value $190.44 vs Price $187.60 - GuruFocus
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Becton Dickinson and Co stock hits 52-week high at 187.5 USD - Investing.com Nigeria
Becton, Dickinson and Company (NYSE:BDX) Reaches New 1-Year HighWhat's Next? - MarketBeat
What's Going On With Becton Dickinson Stock Wednesday? - Benzinga
Mitsubishi UFJ Asset Management Co. Ltd. Makes New Investment in Becton, Dickinson and Company $BDX - MarketBeat
Pallas Capital Advisors LLC Takes $920,000 Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):